By Tom Fish ( February 15, 2024, 1:33 PM GMT) -- GSK said Thursday that it has finalized the purchase of asthma drug developer Aiolos Bio Inc. for up to $1.4 billion, as the U.K. pharmaceuticals giant adds a potentially revolutionary respiratory treatment to its portfolio....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.